Takeda nearing agreement to buy Shire for $60B — 4 insights

Takeda Pharmaceuticals is nearing an agreement to acquire Shire for approximately $60 billion, the Chicago Tribune reports.

Here's what you should know.

1. People with knowledge of the matter said the companies are attempting to reach a tentative agreement on price, with a potential announcement as soon as May 1.

2. In accordance with U.K. takeover rules, Takeda must announce a preliminary agreement by May 2 or it'll have to abandon the bid.

3. Sources told the Tribune the companies are seeking a possible extension.

4. Talks are still progressing and are fluid. The final figure may vary drastically from the rumored $60 billion.

Copyright © 2024 Becker's Healthcare. All Rights Reserved. Privacy Policy. Cookie Policy. Linking and Reprinting Policy.

 

Featured Webinars

Featured Whitepapers

Featured Podcast